Re: We get a mention...
in response to
by
posted on
Apr 12, 2012 01:48PM
Edit this title from the Fast Facts Section
No surprise here...
Apr 12, 2012 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Biotechnology industry with the highest debt to asset ratios. The Debt/Asset ratio shows the proportion of a company's assets that are financed through debt. If the ratio is greater than one, most of the company's assets are financed through debt.Anavex Life Sciences ranks highest with a a debt to asset ratio of 13.67. Talon Therapeutics is next with a a debt to asset ratio of 4.21. Unigene Laboratories ranks third highest with a a debt to asset ratio of 2.84.
"MannKind follows with a a debt to asset ratio of 2.44, and NeurogesX rounds out the top five with a a debt to asset ratio of 1.72.
SmarTrend recommended that its subscribers protect gains by selling shares of Unigene Laboratories on February 28th, 2012 by issuing a Downtrend alert when the shares were trading at $0.49. Since that call, shares of Unigene Laboratories have fallen 15.5%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.
http://financial.tmcnet.com/news/2012/04/12/6254571.htm